Andreas Trojan

2.5k citations
63 papers · 2k · h-index 22

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
  • Immunology top 5%
    • Immunotherapy and Immune Responses

Papers in

    • Cancer survivorship and care 7
    • Cancer Immunotherapy and Biomarkers 3
    • Immunotherapy and Immune Responses 8

Andreas Trojan

61 papers receiving 2k citations

Peers

Andreas Trojan
Comparison fields: 5 of 96
  • Oncology 498
  • Immunology 377
  • Hematology 190
  • Genetics 110
  • Cancer Research 140
Replace R. Russell‐Jones with:
R. Russell‐Jones United Kingdom
Winand Lange Germany
Isamu Makino Japan
Zubin M. Bamboat United States
Sarah A. Taylor United States
Uri Rozovski Israel
Ryoichi Imamura Japan
Shelley L. Rasmussen United States
John J. Costanzi United States
Masahide Yamamoto Japan
Andreas Trojan relative to R. Russell‐Jones United Kingdom R. Russell‐Jones's profile →
Citations per field
00.5×1.5×2×
R. Russell‐Jones · 1×
Citations per year

Countries citing papers authored by Andreas Trojan

Since Specialization
Citations

This map shows the geographic impact of Andreas Trojan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Trojan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Trojan more than expected).

Fields of papers citing papers by Andreas Trojan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Trojan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Trojan. The network helps show where Andreas Trojan may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas Trojan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas Trojan Line = papers co-authored together Andreas Trojan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2002194
2 2007183
3 2001181
4 2000147
5 2008111
6 200499
7 200086
8 201279
9 201679
10 200575
11 200258
12 201352
13 200148
14 200443
15 201643
16
Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule.
200142
17 201439
18 200929
19 201229
20 201327

About Andreas Trojan

Andreas Trojan is a scholar working on Oncology, Immunology, Cancer Research, Hematology and General Health Professions, having authored 63 papers that have together received 2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer survivorship and care (7 papers), Breast Cancer Treatment Studies (7 papers), Multiple Myeloma Research and Treatments (6 papers), Mobile Health and mHealth Applications (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Advanced Breast Cancer Therapies (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Oncology (498 citations), Immunology (377 citations), Hematology (190 citations), Genetics (110 citations) and Cancer Research (140 citations). Andreas Trojan has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Bernard Burnand, Mathias Witzens‐Harig, John G. Gribben, Rolf Arno Stahel, John W. Donovan, Marco Ladetto, Mirjana Urosevic, Christian Taverna, Reinhard Dummer and Walter Weder. Their work appears in journals such as Annals of Oncology, Blood, Lung Cancer, Breast Care and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact